+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Valganciclovir"

From
From
Cytomegalovirus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Cytomegalovirus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
From
Antiviral Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Antiviral Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Valganciclovir is an antiviral drug used to treat infections caused by certain viruses, such as cytomegalovirus (CMV). It is used in the treatment of infectious diseases, including CMV retinitis, a viral infection of the retina that can cause blindness. Valganciclovir is also used to prevent CMV infection in people who have received organ transplants. It works by blocking the action of the virus in the body, preventing it from multiplying and spreading. Valganciclovir is available in tablet and oral solution form. It is usually taken twice daily, with or without food. Common side effects include nausea, vomiting, diarrhea, and headache. More serious side effects may include kidney problems, anemia, and low white blood cell count. Valganciclovir is marketed by several pharmaceutical companies, including Genentech, Merck, and Novartis. It is also available as a generic drug. Show Less Read more